Human papillomavirus and cancerous diseases of the head and neck: A systematic review and meta-analysis

Oral Diseases

Volumn 21, Issue 4, 2015, Pages 417-431

  Saulle, R ^a   Semyonov, L ^a   Mannocci, A ^a   Careri, A ^b   Saburri, F ^b   Ottolenghi, L ^b   Guerra, F ^b   La Torre, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Head and neck cancer; Human papillomavirus; Meta analysis; Observational studies; Risk; Systematic review

Indexed keywords

WART VIRUS VACCINE;

CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CLINICAL PRACTICE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LARYNX; META ANALYSIS (TOPIC); MOUTH CAVITY; OBSERVATIONAL STUDY; PAPILLOMAVIRUS INFECTION; PHARYNX; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; WART VIRUS; HEAD AND NECK TUMOR; ISOLATION AND PURIFICATION; META ANALYSIS; PAPILLOMAVIRIDAE; SQUAMOUS CELL CARCINOMA; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 84927670412     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12269     Document Type: Review

References (97)

1. Alvarez Alvarez I, Sánchez Lazo P, Ramos González S, Rodrigo Tapia JP, Llorente Pendas JL, Suárez Nieto C (1996). Simultaneous screening of HPV-6b and 16 in pharyngolaryngeal cancer [Detección simultánea del HPV-6b y 16 en el cáncer faringolaríngeo]. Acta Otorrinolaringol Esp 47: 93-96.
2. Angiero F, Gatta LB, Seramondi R (2010). Frequency and role of HPV in the progression of epithelial dysplasia to oral cancer. Anticancer Res 30: 3435-3440.
3. Attner P, Du J, Näsman A, Hammarstedt L (2010). The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer 126: 2879-2884.
4. Badaracco G, Venuti A, Morello R, Muller A, Marcante ML (2000). Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res 20: 1301-1305.
5. Báez A, Almodóvar JI, Cantor A, Celestin F, Cruz-Cruz L, Fonseca S (2004). High frequency of HPV16 associated head and neck squamous cell carcinoma in the Puerto Rican population. Head Neck 26: 778-784.
6. Baseman JG, Koutsky LA (2005). The epidemiology of human papillomavirus infections. J Clin Virol 32(Suppl 1): S16-S24.
7. Baumann JL, Cohen S, Evjen AN (2009). Human papillomavirus in early laryngeal carcinoma. Laryngoscope 119: 1531-1537.
8. Begum S, Cao D, Gillison M, Zahurak M, Westra WH (2005). Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 11: 5694-5699.
9. Bernauer HS, Welkoborsky HJ, Tilling A, Amedee RG, Mann WJ (1997). Inverted papillomas of the paranasal sinuses and the nasal cavity: DNA indices and HPV infection. Am J Rhinol 11: 155-160.
10. Bradford CR, Zacks SE, Androphy EJ, Gregoire L, Lancaster WD, Carey TE (1991). Human papillomavirus DNA sequences in cell lines derived from head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg 104: 303-310.
11. Brandsma JL, Abramson AL (1989). Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 115: 621-625.
12. Brandwein MS, Nuovo GJ, Biller H (1993). Analysis of prevalence of human papillomavirus in laryngeal carcinomas. Study of 40 cases using polymerase chain reaction and consensus primers. Ann Otol Rhinol Laryngol 102: 309-313.
13. Chiominto A, Giannoni M, Ventura L, Ranieri A (1995). Epidermoid carcinoma of the oral cavity. Considerations of the role of the papillomavirus. Minerva Stomatol 44: 127-132.
14. Clayman GI, Stewart MG, Weber RS, El-Naggar AK, Grimm EA (1994). Human papillomavirus in laryngeal and hypopharyngeal carcinomas: relationship to survival. Arch Otolaryngol Head Neck Surg 120: 743-748.
15. Consiglio Nazionale delle Ricerche, Ministero dell'Istruzione, dell'Università (1999). Linee Guida Progetto Strategico Oncologia BRIDGE: I tumori epiteliali della testa e del collo. Available at: http://progettooncologia.cnr.it/bridge/testaecollo/indice-tc.html [accessed on 25 July 2013].
16. Crawford R, Grignon AL, Kitson S (2011). High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology. BMC Cancer 11: 473.
17. Dahlstrom KR, Li G, Tortolero-Luna G, Wei Q, Sturgis EM (2011). Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck 33: 847-855.
18. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S (2009). Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 124: 1626-1636.
19. Deng Z, Hasegawa M, Matayoshi S (2011). Prevalence and clinical features of human papillomavirus in head and neck squamous cell carcinoma in Okinawa, southern Japan. Eur Arch Otorhinolaryngol 268: 1625-1631.
20. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
21. D'Souza G, Kreimer AR, Viscidi R (2007). Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356: 1944-1956.
22. Duray A, Descamps G, Arafa M (2011). High incidence of high-risk HPV in benign and malignant lesions of the larynx. Int J Oncol 39: 51-59.
23. Elamin F, Steingrimsdottir H, Wanakulasuriya S, Johnson N, Tavassoli M (1998). Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in U.K. subjects: a novel method of detection. Oral Oncol 34: 191-197.
24. El-Mofty SK, Lu DW (2003). Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 27: 1463-1470.
25. Fliss DM, Noble-Topham SE, McLachlin CM (1994). Laryngeal verrucous carcinoma: a clinicopathologic study and detection of human papillomavirus using polymerase chain reaction. Laryngoscope 104: 146-152.
26. Furniss CS, McClean MD, Smith JF (2007). Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer 120: 2386-2392.
27. Furniss CS, Marsit CJ, Houseman EA, Eddy K, Kelsey KT (2008). Line region hypomethylation is associated with lifestyle and differs by human papillomavirus status in head and neck squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 17: 966-971.
28. Furuta Y, Takasu T, Asai T (1992). Detection of human papillomavirus DNA in carcinomas of the nasal cavities and paranasal sinuses by polymerase chain reaction. Cancer 69: 353-357.
29. Gallegos-Hernández JF, Paredes-Hernández E, Flores-Díaz R, Minauro-Muñoz G, Apresa-García T, Hernández-Hernández DM (2007). Human papillomavirus: association with head and neck cancer. Cir 75: 151-155.
30. Garotta M, Occhini A, Bertino G, Morbini P, Benazzo M (2011). Il ruolo del Papillomavirus (HPV) nella patologia neoplastica della laringe [The role of papillomavirus (HPV) in neoplastic disease of the larynx]. Bollettino della Società Medico Chirurgica di Pavia 124: 151-168.
31. Gasparini R, Panatto D (2009). Cervical cancer: from Hippocrates through Rigoni-Stern to zur Hausen. Vaccine 27(Suppl 1): A4-A5.
32. Gillison ML, Alemanyb L, Snijdersd PJF (2012). Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine 30: 34-54.
33. Gorgoulis V, Rassidakis G, Karameris A, Giatromanolaki A, Barbatis C, Kittas C (1994). Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings. Virchows Arch 425: 481-489.
34. Gorgoulis VG, Zacharatos P, Kotsinas A (1999). Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 30: 274-283.
35. Gudleviciene Z, Smailyte G, Mickonas A, Pikelis A (2009). Prevalence of human papillomavirus and other risk factors in Lithuanian patients with head and neck cancer. Oncology 76: 205-208.
36. Hai-Rong J, Peng W, Yong L, Tao N, Xiao-Song R, Bao-Guo L (2010). Detection of human papilloma virus type 16 E6 mRNA in laryngeal squamous cell carcinoma by in situ hybridization. Chin J Cancer Res 22: 218-223.
37. Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J (2006). Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119: 2620-2623.
38. zur Hausen H (2009). Papillomaviruses in the causation of human cancers-a brief historical account. Virology 384: 260-265.
39. Herrero R, Castellsagué X, Pawlita M (2003). Human papillomavirus and oral cancer: the International Agency for research on cancer multicenter study. J Natl Cancer Inst 95: 1772-1783.
40. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ (2006). Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 31: 259-266.
41. Hocking JS, Stein A, Conway EL (2011). Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 104: 886-891.
42. Holladay EB, Gerald WL (1993). Viral gene detection in oral neoplasms using the polymerase chain reaction. Am J Clin Pathol 100: 36-40.
43. Huang CC, Hsiao JR, Yang MW (2011). Human papilloma virus detection in neoplastic and non-neoplastic nasopharyngeal tissues in Taiwan. J Clin Pathol 64: 571-577.
44. Ioannidis JP (2008). Interpretation of tests of heterogeneity and bias in metaanalysis. J Eval Clin Pract 14: 951-957.
45. Jayaprakash V, Reid M, Hatton E, Merzianu M, Rigual N, Marshall J (2011). Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis. Oral Oncol 47: 1048-1054.
46. Jo VY, Mills SE, Stoler MH, Stelow EB (2009). Papillary squamous cell carcinoma of the head and neck: frequent association with human papillomavirus infection and invasive carcinoma. Am J Surg Pathol 33: 1720-1724.
47. Kaya H, Kotiloglu E (2001). Prevalence of human papillomavirus (HPV) DNA in larynx and lung carcinomas. Pathologica 93: 531-534.
48. Kleist B, Bankau A, Lorenz G, Jäger B, Poetsch M (2004). Different risk factors in basaloid and common squamous head and neck cancer. Laryngoscope 114: 1063-1068.
49. Klussmann JP, Weissenborn SJ, Wieland U (2001). Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 92: 2875-2884.
50. Koppikar P, De Villiers EM, Mulherkar R (2005). Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. Int J Cancer 113: 946-950.
51. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005). Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14: 467-475.
52. Kreimer AR, Bhatia RK, Messeguer AL, Gonzalez P, Herrero R, Giuliano AR (2010). Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 37: 386-391.
53. La Torre G, Chiaradia G, Gianfagna F, De Laurentis A, Boccia S, Ricciardi W (2006). Quality assessment in meta-analysis. Ital J Public Health 3: 44-50.
54. Lee NK, Ritter DB, Gross AE, Myssiorek DJ, Kadish AS, Burk RD (1988). Head and neck squamous cell carcinomas associated with human papillomaviruses and an increased incidence of cervical pathology. Otolaryngol Head Neck Surg 99: 296-301.
55. Lee LA, Cheng AJ, Fang TJ (2008). High incidence of malignant transformation of laryngeal papilloma in Taiwan. Laryngoscope 118: 50-55.
56. Lee SY, Cho NH, Choi EC, Kim WS, Kim SH (2011). Is human papillomavirus a causative factor of glottic cancer? J Voice 25: 770-774.
57. Liberati A, Altman DG, Tetzlaff J, Murlow C, Gøtzsche PC, Ioannidis JPA (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ital J Public Health 6: 354-391.
58. Lie ES, Karlsen F, Holm R (1996). Presence of human papillomavirus in squamous cell laryngeal carcinomas. A study of thirty-nine cases using polymerase chain reaction and in situ hybridization. Acta Otolaryngol 116: 900-905.
59. Lindeberg H, Krogdahl A (1999). Laryngeal cancer and human papillomavirus: HPV is absent in the majority of laryngeal carcinomas. Cancer Lett 146: 9-13.
60. Lo EJ, Bell D, Woo JS (2010). Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope 120: 1990-1997.
61. Lundberg M, Leivo I, Saarilahti K, Måkitie AA, Mattila PS (2011). Increased incidence of oropharyngeal cancer and p16 expression. Acta Otolaryngol 131: 1008-1011.
62. MacHado J, Reis PP, Zhang T (2010). Low prevalence of human papillomavirus in oral cavity carcinomas. Head Neck Oncol 2: 2-6.
63. Maden C, Beckmann AM, Thomas DB (1992). Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol 135: 1093-1102.
64. Mancilla LI, Carrascal E, Tamayo OM (2011). Role of human papillomavirus type 16 in squamous cell carcinoma of upper aerodigestive tracts in Colombian patients. Int J Cancer 7: 222-232.
65. Matzow T, Boysen M, Kalantari M, Johansson B, Hagmar B (1998). Low detection rate of HPV in oral and laryngeal carcinomas. Acta Oncol 37: 73-76.
66. Morgan DW, Abdullah V, Quiney R, Myint S (1991). Human papilloma virus and carcinoma of the laryngopharynx. J Laryngol Otol 105: 288-290.
67. Mork J, Lie AK, Glattre E (2001). Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344: 1125-1131.
68. Muñoz N, Bosch FX, de Sanjosé S et al, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
69. Noble-Topham SE, Fliss DM, Hartwick RWJ (1993). Detection and typing of human papillomavirus in verrucous carcinoma of the oral cavity using the polymerase chain reaction. Arch Otolaryngol Head Neck Surg 119: 1299-1304.
70. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
71. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP (1997). Human papillomavirus (HPV) in head and neck cancer: an association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 79: 595-604.
72. Perez-Ayala M, Ruiz-Cabello F, Esteban F (1990). Presence of HPV 16 sequences in laryngeal carcinomas. Int J Cancer 46: 8-11.
73. Portugal LG, Goldenberg JD, Wenig BL (1997). Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 123: 1230-1234.
74. Premoli-De-Percoco G, Ramirez JL (2001). High risk human papillomavirus in oral squamous carcinoma: evidence of risk factors in a Venezuelan rural population. Preliminary report. J Oral Pathol Med 30: 355-361.
75. Reidy PM, Dedo HH, Rabah R, Field JB, Mathog RH, Gregoire L (2004). Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope 114: 1906-1909.
76. Rodrigo JP, Alvarez I, Martinez JA, Lazo PS, Ramos S, Suarez C (1999). Relationship of human papillomavirus to ploidy in squamous cell carcinomas of the head and neck. Otolaryngol Head Neck Surg 121: 318-322.
77. Romanitan M, Näsman A, Ramqvist T et al (2008). Human papillomavirus frequency in oral and oropharyngeal cancer in Greece. Anticancer Res 28: 2077-2080.
78. Ryerson AB, Peters ES, Coughlin SS (2008). Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 113(Suppl 10): 2901-2909.
79. Shen J, Tate JE, Crum CP, Goodman ML (1996). Prevalence of human papillomaviruses (HPV) in benign and malignant tumors of the upper respiratory tract. Mod Pathol 9: 15-20.
80. Simonato LE, Garcia JF, Sundefeld ML, Mattar NJ, Veronese LA, Miyahara GI (2008). Detection of HPV in mouth floor squamous cell carcinoma and its correlation with clinicopathologic variables, risk factors and survival. J Oral Pathol Med 37: 593-598.
81. Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH (1998). Human papillomavirus and risk of oral cancer. Laryngoscope 108: 1098-1103.
82. Smith EM, Summersgill KF, Allen J (2000). Human papillomavirus and risk of laryngeal cancer. Ann Otol Rhinol Laryngol 109: 1069-1076.
83. Smith EM, Ritche JM, Summersgill KF (2004). Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 96: 449-455.
84. Smith EM, Pawlita M, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP (2010). Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer. Int J Cancer 127: 111-117.
85. Snijders PJF, Scholes AGM, Hart CA (1996). Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinomas of the head and neck. Int J Cancer 66: 464-469.
86. Stephen JK, Chen KM, Shah V (2012). Human papillomavirus outcomes in an access-to-care laryngeal cancer cohort. Otolaryngol Head Neck Surg 146: 730-738.
87. Stroup DF, Berlin JA, Morton SC et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
88. Syrjänen K, Syrjänen S, Lamberg M, Pyrhönen S, Nuutinen J (1983). Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 12: 418-424.
89. Tachezy R, Klozar J, Saláková M (2005). HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. Oral Dis 11: 181-185.
90. Thavaraj S, Stokes A, Guerra E (2011). Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol 64: 308-312.
91. Torrente MC, Ampuero S, Abud M, Ojeda JM (2005). Molecular detection and typing of human papillomavirus in laryngeal carcinoma specimens. Acta Otolaryngol 125: 888-893.
92. Tsuchiya H, Tomita Y, Shirasawa H, Tanzawa H, Sato K, Simizu B (1991). Detection of human papillomavirus in head and neck tumors with DNA hybridization and immunohistochemical analysis. Oral Surg Oral Med Oral Pathol 71: 721-725.
93. Venuti A, Manni V, Morello R, De Marco F, Marzetti F, Marcante ML (2000). Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol 60: 396-402.
94. Venuti A, Badaracco G, Rizzo C, Mafera B, Rahimi S, Vigili M (2004). Presence of HPV in head and neck tumours: high prevalence in tonsillar localization. J Exp Clin Cancer Res 23: 561-566.
95. Wang H, Lin YC, Kang XS (1991). Detection of human papilloma virus (HPV) in laryngeal carcinoma tissue. Chin Med J 104: 523-525.
96. Watts SL, Brewer EE, Fry TL (1991). Human papillomavirus DNA types in squamous cell carcinomas of the head and neck. Oral Surg Oral Med Oral Pathol 71: 701-707.
97. Woods KV, Shillitoe EJ, Spitz MR, Schantz SP, Adler-Storthz K (1993). Analysis of human papillomavirus DNA in oral squamous cell carcinomas. J Oral Pathol Med 22: 101-108.